Making a Difference, Here & Beyond
The community invests in Dell Med. In return, it’s our responsibility — one we take seriously — to be agents for change and to show real impact.
More Information
Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
More Information
Let’s Do Big Things Together
True health demands that the whole work in harmony, which is why we’re dedicated to partnership. Indeed, we can’t achieve our goals without it.
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
More Information
Make an Appointment Directory Give Faculty Students

Venture Capital for Health IT

Location: Health Discovery Building Auditorium

Address: 1601 Trinity St., Building B, Austin, Texas 78701 | View Map »

Date: Thursday, August 29, 2019

Time: 3–4:30 p.m.

Contact: Verena Kallhoff

About the Event

With the cost of technologies declining, why has the cost of health tech continued to rise? Can hospitals afford the latest innovations? This presentation will cover market needs and investment trends in health IT and explore whether or not the two are aligned.

Join us for the August installment of the Texas Health CoLab Learning Series to discover how the influx of capital has impacted the health care industry.

About the Speaker

Emma Cartmell is a proven health tech investor, following a 20-year career building, acquiring, selling and taking companies public. Cartmell served as the COO of NantHealth, a $1 billion private equity fund, where she built the team and led investments and acquisitions. Before that, Cartmell was the COO of personalized medicine at Abraxis BioScience, where she prepared the company for sale and helped negotiate an eight-times revenue sale to Celgene for $2.9 billion. Earlier in her career, she was vice president of health care advanced programs and director of business development at SAIC, where she held both P&L and revenue-generating responsibilities for a $500 million health care business. Cartmell has developed M&A strategies for public and private companies on both the buy- and sell-side, with investment targets of up to $1 billion. She also advises the Morgan Stanley Equity Research team on the digital health market. She personally invests in health care technology startups, both individually and as a member of the Central Texas Angel Network.